Building the Innovation Bridge Between Japan and the World

August 25, 2026August 25, 2026 ~ Next Phase Admin ~ Leave a comment

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

Japan has world-class science, deep pharmaceutical expertise, and a rich pipeline of emerging life science technology. It is now delivering an innovation bridge that connects that innovation to the global life science community.

At RESI Boston 2026, our 8th annual Global Family Office BioForum Luncheon will bring together international family offices for a private, invitation-only conversation about the emerging bridge between Japan and the rest of the world. I will be joined by Keiko Kobayashi of the Kobe Biomedical Innovation Cluster (KBIC) and Rick Berenson, Managing Director of Venzyme Catalyst.

KBIC is one of Japan’s largest life science clusters, and our work together is centered on three objectives: helping Japanese technology assets enter the global arena, bringing international investors and strategic partners closer to Japan’s innovation ecosystem, and fostering cross-border investment syndicates that connect Japanese and international investors around opportunities in both markets.

The pieces are coming together. KBIC brings the Japanese ecosystem, company pipeline, and government relationships. Venzyme Catalyst brings early-stage assessment, shaping, and de-risking. LSN brings commercialization preparation, RESI, BD Assist, and its global network of investors and licensing partners. Keiko will share what KBIC is building in Japan, while Rick and I will explain how the commercialization engine connects regional innovation to the global marketplace.

Then we will do what has made the BioForum work for eight years: get out of the way and let the room work. The real value is the conversation among family offices as they compare perspectives, share experiences, and build relationships with peers. Attendance is limited and by invitation only. Family offices interested in attending can reply to this newsletter or contact Life Science Nation to request an invitation.

Global Family Office BioForum Luncheon
Tuesday, September 22, 2026, 12:00 to 1:00 pm
Westin Copley Place, Boston
Private and invitation only

RSVP for GFOB Here

Featuring:

Dennis Ford

Founder of Life Science Nation, Creator of RESI, and Architect of LSN Labs

Rick Berenson

Managing Director, Venzyme Catalyst

Keiko Kobayashi

Business Strategies, Head of International Ecosystem Development, KBIC

More Investors. More Opportunities. More Momentum.

August 11, 2026August 11, 2026 ~ Next Phase Admin ~ Leave a comment

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

Investor interest in RESI Boston is building quickly as the launch of the RESI partnering platform approaches on Monday, August 17. With partnering just days away, investor registrations are expected to accelerate further as firms prepare to identify companies and begin scheduling one-on-one meetings.

In five days of investor registration, more than 30 investor firms signed up to participate, reinforcing RESI’s position as one of the premier partnering events for early-stage life science companies seeking capital and strategic partnerships.

Recently Confirmed Investors (Last 5 Days)

Explore the full RESI Boston investor list here.

These new registrations join a growing community of investors from across venture capital, corporate venture, family offices, angel groups, foundations, and strategic investment organizations, creating even more opportunities for meaningful one-on-one meetings.

🏷️ Save $300 on RESI Boston Registration

Secure your pass before Early Bird rates end this Friday, August 14th to get full access to investor partnering!

Already, more than 200 investors representing over 150 global investor firms have registered for RESI Boston, with additional investors continuing to join each week.

As the investor roster continues to grow, so do the opportunities to connect with the partners who can help move your company forward.

Register now to join one of the industry’s most active life science partnering events. Early Bird pricing ends Friday, August 14, giving attendees one last opportunity to save $300 before standard rates take effect.

Partnering Launches August 17 for RESI Boston September 2026

August 11, 2026 ~ Next Phase Admin ~ Leave a comment

By Max Braht, VP of Business Development, LSN

RESI Boston September 2026 brings together one of the largest gatherings of early-stage life science investors, pharmaceutical and medtech business development professionals, strategic partners, and innovators during Biotech Week Boston. With two days of in-person networking, educational panels, company presentations, the Innovator’s Pitch Challenge, an active exhibit hall, and dedicated one-on-one partnering, RESI is designed to help emerging life science companies build the relationships that drive fundraising, licensing, strategic partnerships, and commercialization.

One of the event’s most valuable features launches Monday, August 17: the RESI partnering platform.

Beginning August 17, registered attendees can start scheduling one-on-one meetings with investors, pharmaceutical business development teams, strategic partners, and service providers well in advance of the conference.

The RESI series continues to be one of the world’s largest early-stage life science partnering events, bringing together hundreds of active investors and strategic partners focused on biotechnology, AI, medical devices, diagnostics, digital health, and life science tools. Whether attending in person or virtually, participants can use Life Science Nation’s (LSN) proprietary partnering platform to identify organizations that align with their technology, stage of development, therapeutic focus, and fundraising objectives.

Launching your partnering outreach early is one of the best ways to maximize your RESI experience. Companies that complete their profiles and begin requesting meetings as soon as partnering opens gain greater visibility and have more opportunities to secure valuable conversations before schedules begin to fill.

To help attendees make the most of the partnering platform, Life Science Nation will host a complimentary RESI Boston Partnering Tutorial webinar on Tuesday, August 18, at 9:00 AM MT. During this interactive session, LSN staff will demonstrate how to:

Build a compelling partnering profile
Identify investors and strategic partners that best fit your company
Develop an outreach strategy that increases meeting acceptance
Manage meeting requests and follow up effectively
Leverage the partnering platform and conference resources to maximize your RESI experience

🎓 Free Webinar: RESI Partnering Tutorial

Learn outreach strategies to maximize your 1-on-1 investor meetings. Tuesday, Aug 18 @ 11:00 AM ET

Whether you are attending RESI for the first time or are a returning participant, this tutorial offers practical strategies to help you secure more meaningful meetings and maximize your return on investment.

Register now to secure your $300 Early Bird savings before August 14, complete your partnering profile, begin requesting meetings when the platform opens on August 17, and join the complimentary Partnering Tutorial on August 18 to position your company for a productive and successful RESI Boston September 2026.

🏷️ Save $300 on RESI Boston Registration

Secure your pass before Early Bird rates end this Friday, August 14th to get full access to investor partnering!

Establish Your Innovation Hub at RESI JPM 2027

August 4, 2026 ~ Next Phase Admin ~ Leave a comment

By Max Braht, VP of Business Development, LSN

Every January, JPM Healthcare Week transforms San Francisco into the global center of the life science industry, bringing together investors, pharmaceutical executives, biotech leaders, and innovators from around the world. For organizations looking to showcase their regional ecosystem, portfolio companies, or innovation network, RESI JPM 2027 offers a unique opportunity to establish a visible and strategic presence during one of the industry’s most influential weeks.

Located within the San Francisco Marriott Marquis, RESI JPM is the premier partnering conference dedicated to early-stage life science companies. The event connects startups with active investors, strategic partners, and business development professionals through curated partnering meetings, educational programming, and networking opportunities.

Life Science Nation invites regional organizations, innovation hubs, accelerators, and industry partners to create their own branded Innovation Hub alongside RESI JPM. These flexible hosting opportunities allow organizations to provide a central gathering place for their ecosystem while taking advantage of the high concentration of attendees already participating in RESI and JPM Healthcare Week.

RESI JPM 2027 Venue: Salons 9–15 (Yerba Buena Ballroom, Lower B2 Level) with total space exceeding 17,000 sq ft.

Organizations can kick off the week with a private networking reception on Sunday, welcoming investors, founders, corporate partners, and key stakeholders before the week’s meetings begin. During RESI JPM on Monday and Tuesday, dedicated salon spaces adjacent to the conference offer an ideal location for hosting meetings, showcasing portfolio companies, conducting presentations, and serving as a home base for delegates throughout the event.

Tech/Innovation hubs also benefit from prominent branding within the RESI environment and the opportunity for their startup cohorts to engage directly in RESI’s partnering platform, creating additional exposure and meeting opportunities with investors and strategic partners.

Whether representing a regional life science cluster, government agency, incubator, accelerator, or investment organization, establishing an Innovation Hub at RESI JPM positions your organization at the center of the world’s largest life science partnering week while providing lasting value for your innovation ecosystem.

To learn more about creating an Innovation Hub at RESI JPM 2027, contact Life Science Nation at salescore@lifesciencenation.com.

Gearing Up for RESI Boston: Master Your Fundraising & Development Strategy at the Pre-RESI Biotech Forum

July 28, 2026 ~ Next Phase Admin ~ Leave a comment

By Max Braht, VP of Business Development, LSN

On Monday, September 21, 2026, the day before RESI Boston 2026, Life Science Nation (LSN) and RESI Boston Silver Sponsor, Certara, will host a Biotech Forum focused on Developing Investor Ready Strategies.

Designed for early-stage biotech companies, the workshop will help founders evaluate their company’s readiness for a global fundraising campaign by identifying opportunities to strengthen their development strategy and reduce key scientific, clinical, regulatory, commercial, and fundraising risks. Through expert-led sessions and interactive discussions, attendees will gain practical insights into what investors look for during diligence, how to build a credible development roadmap, and how to position their company for successful fundraising.

Held immediately before RESI Boston, the workshop gives companies the opportunity to refine their strategy and messaging before meeting with investors and strategic partners throughout RESI.

Not yet signed up for RESI Boston 2026: Register Here

We look forward to welcoming you to the CIC in Cambridge as we kick off RESI Boston 2026 with a day dedicated to helping innovative biotech companies become truly investor ready.

Finding the Right Investors Starts with the Right Data

July 21, 2026July 21, 2026 ~ Next Phase Admin ~ Leave a comment

By Max Braht, VP of Business Development, LSN

For early-stage life science companies, fundraising success depends on connecting with investors who are actively looking for technologies like yours. That is why Life Science Nation (LSN) has spent years building one of the industry’s most comprehensive investor databases, designed specifically to help innovators identify the right capital partners.

Unlike generic databases built through web scraping, the LSN Investor Database is curated directly through 1:1 interviews with investors and strategic in-licensors, providing startups with insights that go far beyond basic contact information or what you find on an investor’s website. Each investor profile includes valuable details such as typical check size, preferred modalities and indications, stage of development, geographic focus, and more, allowing companies to build a highly targeted fundraising strategy.

The database includes more than 4,000 global investment firms across 10 distinct investor categories and over 12,000 investor contacts spanning therapeutics, medical devices, diagnostics, digital health, and other life science sectors. Whether you are raising a Seed, Series A, or Series B round, identifying investors who are an actual fit can save significant time and improve the quality of your outreach.

Not sure where to begin? Life Science Nation is offering a complimentary investor search to help companies uncover potential investors that may not already be on their radar. The search demonstrates how the LSN Investor Database can provide each company with a curated list of investors matched to their technology and stage of development, along with contact information to then go out and execute on a fundraising campaign.

LSN is also happy to offer a free Fundraising Readiness Assessment through our internally developed AI Agent. The assessment will generate a 6-page report that can be used to help transition your companies’ story from an “interesting technology” into a compelling and ultimately investable company.

Book your free investor search today or complete the AI assessment to take the first step toward building a more focused and effective fundraising campaign.

Book Your Free Investor Search Today

RESI Boston 2026 Agenda Announced: Two Days of Investor Insights, Partnership Strategy, and Networking

July 14, 2026July 14, 2026 ~ Next Phase Admin ~ Leave a comment

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

The agenda for RESI Boston 2026 is here, offering attendees an in-depth look at the conversations shaping the future of early-stage life science investment. Taking place September 22–23 at The Westin Copley Place in Boston, followed by virtual partnering days on September 25, 28, and 29, the expanded two-day in-person conference delivers more opportunities than ever to connect with investors, strategic partners, and industry leaders.

This year’s program reflects the evolving priorities of the healthcare investment ecosystem, with sessions designed to help innovators better understand today’s fundraising environment while building the relationships needed to move their companies forward.

Day one begins by exploring why Boston remains one of the world’s premier biotechnology hubs before examining key topics including partnering with health systems, how venture investors evaluate early-stage therapeutics, securing pharmaceutical partnerships, corporate venture capital strategies, digital health innovation, and the growing influence of family offices in healthcare investing. The day also features the Global Family Office Bioforum (GFOB), an invite-only private networking lunch that brings together select family office investors for high-value discussions and relationship building.

On day two, programming shifts toward emerging investment trends with sessions highlighting angel investing, women’s health, impact investing, and the increasingly important role of mission-driven capital. The conference concludes with two Reverse VC Pitch sessions, where investors take the stage to present directly to entrepreneurs, providing attendees with valuable insight into investment priorities, fund strategies, and what investors are actively seeking in new opportunities. The day also features the exclusive Global VC Connect Lunch, creating another dedicated opportunity for venture capital investors to build meaningful connections.

As always, RESI programming is designed to provide practical insights rather than theory. Whether attendees are preparing for their next fundraising round, pursuing strategic partnerships, or looking to better understand today’s investment landscape, every panel is curated to deliver actionable perspectives from experienced investors and industry leaders.

Combined with RESI’s partnering platform and three additional days of virtual meetings, the conference offers a comprehensive environment for companies seeking to advance fundraising and business development efforts.

Join the RESI Speaker Lineup

Are you an investor or strategic partner with valuable insights to share with early-stage life science companies? We are looking for dynamic speakers to join our RESI panels. Click here to submit your Speaker Interest Form today!

Registration is now open, with super early bird pricing currently available. Companies planning to attend are encouraged to register early to secure the best available rates and begin preparing for one of the most anticipated life science investment events of the year.